相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibition of GSK3 beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Philip T. T. Ly et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
O-linked beta-N-acetylglucosaminidase inhibitor attenuates beta-amyloid plaque and rescues memory impairment
Chaeyoung Kim et al.
NEUROBIOLOGY OF AGING (2013)
Increasing Brain Protein O-GlcNAc-ylation Mitigates Breathing Defects and Mortality of Tau.P301L Mice
Peter Borghgraef et al.
PLOS ONE (2013)
Alzheimer's Disease and Diabetes: New Insights and Unifying Therapies
Arianna Vignini et al.
CURRENT DIABETES REVIEWS (2013)
Aging brain microenvironment decreases hippocampal neurogenesis through Wnt-mediated survivin signaling
Carlos J. Miranda et al.
AGING CELL (2012)
PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells
Ali Mehdy et al.
JOURNAL OF BIOCHEMISTRY (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2012)
Functional Screening of Alzheimer Pathology Genome-wide Association Signals in Drosophila
Joshua M. Shulman et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP)
Kristin T. Jacobsen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
A Selective Inhibitor Gal-PUGNAc of Human Lysosomal beta-Hexosaminidases Modulates Levels of the Ganglioside GM2 in Neuroblastoma Cells
Keith A. Stubbs et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
Fei Liu et al.
BRAIN (2009)
Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease
Ying Liu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
Ying Liu et al.
FEBS LETTERS (2008)
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Hong Qing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2008)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Sylvie Le Corre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Culturing hippocampal neurons
Stefanie Kaech et al.
NATURE PROTOCOLS (2006)
O-GlcNAcase catalyzes cleavage of thioglycosides without general acid catalysis
MS Macauley et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes
XL Sun et al.
FASEB JOURNAL (2005)
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Multi-metric behavioral comparison of APPsw and P30IL models for Alzheimer's Disease: linkage of poorer cognitive performance to tau pathology in forebrain
GW Arendash et al.
BRAIN RESEARCH (2004)
Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism
K Liu et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex
Y Akimoto et al.
BRAIN RESEARCH (2003)
Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins -: a role in nuclear localization
T Lefebvre et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility
N Sahara et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
J Lewis et al.
SCIENCE (2001)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dynamic O-glycosylation of nuclear and cytosolic proteins -: Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain
Y Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)